Skip to main content

Companies offering Humira (adalimumab)

Humira, whose generic name is adalimumab, is a biologic medication prescribed for inflammatory conditions such as rheumatoid arthritis, psoriatic arthritis, plaque psoriasis, ankylosing spondylitis, Crohn's disease, and ulcerative colitis.

List of companies that offer Humira (adalimumab)

This is sourced from job postings — companies only hire for what they actively use or plan to adopt · how we source this →

CompanyCountryIndustryEmployeesRevenueTechnologies

United States

Pharmaceutical Manufacturing

60k

$26B

Humira (adalimumab)

China

Pharmaceutical Manufacturing

5k

$589M

Humira (adalimumab)

United States

Non-profit Organizations

26

Humira (adalimumab)

United States

Hospitals and Health Care

10k

Humira (adalimumab)

United Kingdom

Hospitals and Health Care

10k

Humira (adalimumab)

United Kingdom

Biotechnology Research

71

$1M

Humira (adalimumab)

United States

Hospitals and Health Care

120

$3.1M

Humira (adalimumab)

United States

Hospitals and Health Care

1k

$6.4M

Humira (adalimumab)

United Kingdom

Hospitals and Health Care

10k

Humira (adalimumab)

United States

Hospitals and Health Care

501

$100M

Humira (adalimumab)

Showing top companies out of 46 that offer Humira (adalimumab). Get the full list on TheirStack.

Frequently asked questions